Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design

Kathleen W. Beekman, A. Dimitrios Colevas, Kathleen Cooney, Robert DiPaola, Rodney L. Dunn, Mitchell Gross, Evan T. Keller, Kenneth J. Pienta, Charles J. Ryan, David Smith, Maha Hussain

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design'. Together they form a unique fingerprint.

Medicine & Life Sciences